Vickerman & Driscoll Financial Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Vickerman & Driscoll Financial Advisors's PFE Position: Q1 2020 in Review
Vickerman & Driscoll Financial Advisors increased its Pfizer (PFE) stake by 56% in Q1 2020, buying an estimated $775K and bringing the position to 63,252 shares worth $1.96M. The position accounts for 1.2% of the portfolio, ranked #26.
Vickerman & Driscoll Financial Advisors first reported a position in PFE in Q4 2017 and has held it in 10 quarters since. 2,438 funds tracked by Wall St. Rank hold PFE as of Q1 2020.
- Vickerman & Driscoll Financial Advisors held 63,252 shares of Pfizer worth $1.96M as of Q1 2020.
- Vickerman & Driscoll Financial Advisors bought 22,756 Pfizer shares in Q1 2020, an estimated $775K.
- Pfizer made up 1.2% of Vickerman & Driscoll Financial Advisors's portfolio in Q1 2020, its #26 holding.
- Vickerman & Driscoll Financial Advisors first reported a position in Pfizer in Q4 2017 and has held it in 10 quarters since.
- 2,438 funds tracked by Wall St. Rank held Pfizer as of Q1 2020.
Based on Vickerman & Driscoll Financial Advisors's 13F filing for Q1 2020, filed 13 May 2020.